Florida has emerged as the top state in the U.S. for economic impact generated by clinical trials, according to a recent report. The state’s robust life sciences infrastructure, supportive policies, and concentration of medical research institutions help drive a thriving clinical trials ecosystem that attracts investment, fuels job growth, and enhances innovation in health care. This leadership position underscores Florida’s growing reputation as a national hub for medical research and development, offering strategic advantages to biotech firms, academic institutions, and health care providers alike.